These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37392341)

  • 21. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications.
    McFadyen JD; Stevens H; Peter K
    Circ Res; 2020 Jul; 127(4):571-587. PubMed ID: 32586214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 infection and thrombotic complications: a narrative review.
    Moschonas IC; Tselepis AD
    J Thromb Thrombolysis; 2021 Jul; 52(1):111-123. PubMed ID: 33449290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia.
    Vincent JL; Levi M; Hunt BJ
    Lancet Respir Med; 2022 Feb; 10(2):214-220. PubMed ID: 34838161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood.
    Kumar R; Rivkin MJ; Raffini L
    J Thromb Haemost; 2023 Sep; 21(9):2313-2326. PubMed ID: 37268064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.
    Maiuolo J; Mollace R; Gliozzi M; Musolino V; Carresi C; Paone S; Scicchitano M; Macrì R; Nucera S; Bosco F; Scarano F; Zito MC; Ruga S; Tavernese A; Mollace V
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombotic events in critically ill children with coronavirus disease 2019 or multisystem inflammatory syndrome in children.
    Dain AS; Raffini L; Whitworth H
    Curr Opin Pediatr; 2022 Jun; 34(3):261-267. PubMed ID: 35634699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thromboembolism in COVID-19: the unsolved problem.
    Casale M; Dattilo G; Imbalzano E; Gigliotti DE Fazio M; Morabito C; Mezzetti M; Busacca P; Signorelli SS; Brunetti ND; Correale M
    Panminerva Med; 2023 Mar; 65(1):51-57. PubMed ID: 32549531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
    Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J
    Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population.
    Poh KC; Jia Tay VY; Lin SH; Chee HL; Thangavelautham S
    Singapore Med J; 2022 Jul; 63(7):350-361. PubMed ID: 33264831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue.
    Varlas VN; Borș RG; Plotogea M; Iordache M; Mehedințu C; Cîrstoiu MM
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial Thrombosis and Acute Limb Ischemia as a Complication of COVID-19 Infection.
    Khryshchanovich VY; Rogovoy NA; Nelipovich EV
    Am Surg; 2023 May; 89(5):2046-2048. PubMed ID: 34049454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of thrombosis after acute-COVID-19 infection.
    Zuin M; Rigatelli G; Zuliani G; Roncon L
    QJM; 2021 Nov; 114(9):619-620. PubMed ID: 33720351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive review of vascular complications in COVID-19.
    Acharya Y; Alameer A; Calpin G; Alkhattab M; Sultan S
    J Thromb Thrombolysis; 2022 Apr; 53(3):586-593. PubMed ID: 34724155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
    Gan R; Rosoman NP; Henshaw DJE; Noble EP; Georgius P; Sommerfeld N
    Med Hypotheses; 2020 Nov; 144():110024. PubMed ID: 32758871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII).
    Oliveira GBF; Neves PDMM; Oliveira HA; Catarino DGM; Alves LBO; Cavalcanti AB; Rosa RG; Veiga VC; Azevedo LCP; Berwanger O; Lopes RD; Avezum Á
    Arq Bras Cardiol; 2023 Mar; 120(3):e20220431. PubMed ID: 37018790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology.
    Patti G; Lio V; Cavallari I; Gragnano F; Riva L; Calabrò P; Di Pasquale G; Pengo V; Rubboli A;
    Am J Cardiovasc Drugs; 2020 Dec; 20(6):559-570. PubMed ID: 33145698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis.
    Płazak W; Drabik L
    Clin Rheumatol; 2023 Oct; 42(10):2691-2702. PubMed ID: 36622519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulant therapy in COVID-19: A narrative review.
    Mohseni Afshar Z; Tavakoli Pirzaman A; Hosseinzadeh R; Babazadeh A; Taghizadeh Moghadam MA; Miri SR; Sio TT; Sullman MJM; Barary M; Ebrahimpour S
    Clin Transl Sci; 2023 Sep; 16(9):1510-1525. PubMed ID: 37326220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection.
    Vagrecha A; Stanco J; Majeed S; Kouides P; Acharya SS
    Haemophilia; 2021 Jul; 27(4):e517-e519. PubMed ID: 33427345
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical Features and Management of COVID-19-Associated Hypercoagulability.
    Massaro G; Lecis D; Martuscelli E; Chiricolo G; Sangiorgi GM
    Card Electrophysiol Clin; 2022 Mar; 14(1):41-52. PubMed ID: 35221084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.